208 related articles for article (PubMed ID: 8611192)
1. The association of vascular proliferation with HPV status and epithelial PCNA positivity in cervical intraepithelial lesions.
Soini Y; Pöllänen R; Kemppainen S; Pääkkö P; Lehto VP
APMIS; 1996 Mar; 104(3):183-90. PubMed ID: 8611192
[TBL] [Abstract][Full Text] [Related]
2. Viral and histopathologic correlates of MN and MIB-1 expression in cervical intraepithelial neoplasia.
Resnick M; Lester S; Tate JE; Sheets EE; Sparks C; Crum CP
Hum Pathol; 1996 Mar; 27(3):234-9. PubMed ID: 8600036
[TBL] [Abstract][Full Text] [Related]
3. Human papillomavirus infection, centrosome aberration, and genetic stability in cervical lesions.
Skyldberg B; Fujioka K; Hellström AC; Sylvén L; Moberger B; Auer G
Mod Pathol; 2001 Apr; 14(4):279-84. PubMed ID: 11301343
[TBL] [Abstract][Full Text] [Related]
4. p53, retinoblastoma gene product, and cyclin protein expression in human papillomavirus virus DNA-positive cervical intraepithelial neoplasia and invasive cancer.
Amortegui AJ; Meyer MP; Elborne VL; Amin RM
Mod Pathol; 1995 Dec; 8(9):907-12. PubMed ID: 8751330
[TBL] [Abstract][Full Text] [Related]
5. Relevance of the rates of PCNA, Ki-67 and p53 expression according to the epithelial compartment in cervical lesions.
Maeda MY; Simões M; Wakamatsu A; Longatto Filho AL; Oyafuso M; de Mello ES; Otta MM; Alves VA
Pathologica; 2001 Jun; 93(3):189-95. PubMed ID: 11433611
[TBL] [Abstract][Full Text] [Related]
6. Up-regulation of proliferating cell nuclear antigen (PCNA) is closely associated with high-risk human papillomavirus (HPV) and progression of cervical intraepithelial neoplasia (CIN), but does not predict disease outcome in cervical cancer.
Branca M; Ciotti M; Giorgi C; Santini D; Di Bonito L; Costa S; Benedetto A; Bonifacio D; Di Bonito P; Paba P; Accardi L; Syrjänen S; Favalli C; Syrjänen K;
Eur J Obstet Gynecol Reprod Biol; 2007 Feb; 130(2):223-31. PubMed ID: 17098349
[TBL] [Abstract][Full Text] [Related]
7. Expression of p53, MDM2, and p21 proteins in high-grade cervical intraepithelial neoplasia and relationship to human papillomavirus infection.
Lie AK; Skarsvåg S; Skomedal H; Haugen OA; Holm R
Int J Gynecol Pathol; 1999 Jan; 18(1):5-11. PubMed ID: 9891236
[TBL] [Abstract][Full Text] [Related]
8. p53 immunoreactivity in cervical intraepithelial neoplasia and non-neoplastic cervical squamous epithelium.
Jeffers MD; Richmond J; Farquharson M; McNicol AM
J Clin Pathol; 1994 Dec; 47(12):1073-6. PubMed ID: 7876377
[TBL] [Abstract][Full Text] [Related]
9. Detection of p53 protein and Ki-67 proliferation antigen in human papillomavirus (HPV)-positive and HPV-negative cervical lesions by immunohistochemical double-staining.
Tervahauta AI; Syrjänen SM; Mäntyjärvi R; Syrjänen KJ
Cytopathology; 1994 Oct; 5(5):282-93. PubMed ID: 7819513
[TBL] [Abstract][Full Text] [Related]
10. Increased Ki-67 proliferative index and absence of P16INK4 in CIN-HPV related pathogenic pathways different from cervical squamous intraepithelial lesion.
Kuo KT; Chang HC; Hsiao CH; Lin MC
Br J Ophthalmol; 2006 Jul; 90(7):894-9. PubMed ID: 16540490
[TBL] [Abstract][Full Text] [Related]
11. Correlation of MIB-1 antigen expression with transcription factors Skn-1, Oct-1, AP-2, and HPV type in cervical intraepithelial neoplasia.
Hietala KA; Kosma VM; Syrjänen KJ; Syrjänen SM; Kellokoski JK
J Pathol; 1997 Nov; 183(3):305-10. PubMed ID: 9422986
[TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical detection of p53 in cervical epithelial lesions with or without infection of human papillomavirus types 16 and 18.
Akasofu M; Oda Y
Virchows Arch; 1995; 425(6):593-602. PubMed ID: 7697216
[TBL] [Abstract][Full Text] [Related]
13. bcl-2 immunoreactivity, human papillomavirus DNA, and cervical intraepithelial neoplasia.
Cooper K; Haffajee Z; Taylor L
Mod Pathol; 1999 Jun; 12(6):612-7. PubMed ID: 10392638
[TBL] [Abstract][Full Text] [Related]
14. [Relationship of Human Papillomavirus Subtypes and Multiple Infection with Different Cervical Precancerous Diseases in Sichuan Province].
Feng YK; Peng Y; Zhu L; Niu XY
Sichuan Da Xue Xue Bao Yi Xue Ban; 2015 May; 46(3):422-5, 462. PubMed ID: 26121866
[TBL] [Abstract][Full Text] [Related]
15. HPV 16 in multiple neoplastic lesions in women with CIN III.
Hennig EM; Di Lonardo A; Venuti A; Holm R; Marcante ML; Nesland JM
J Exp Clin Cancer Res; 1999 Sep; 18(3):369-77. PubMed ID: 10606184
[TBL] [Abstract][Full Text] [Related]
16. [Comparative study of HPV infection and proliferating cell nuclear antigen of uterine cervix].
Murakami T; Nagai N; Ota S; Ohama K
Nihon Sanka Fujinka Gakkai Zasshi; 1993 Sep; 45(9):967-72. PubMed ID: 8103785
[TBL] [Abstract][Full Text] [Related]
17. Telomerase activity, MIB-1, PCNA, HPV 16 and p53 as diagnostic markers for cervical intraepithelial neoplasia.
Herbsleb M; Knudsen UB; Orntoft TF; Bichel P; Norrild B; Knudsen A; Mogensen O
APMIS; 2001 Sep; 109(9):607-17. PubMed ID: 11878714
[TBL] [Abstract][Full Text] [Related]
18. Human papillomavirus (HPV) DNA copy number is dependent on grade of cervical disease and HPV type.
Swan DC; Tucker RA; Tortolero-Luna G; Mitchell MF; Wideroff L; Unger ER; Nisenbaum RA; Reeves WC; Icenogle JP
J Clin Microbiol; 1999 Apr; 37(4):1030-4. PubMed ID: 10074522
[TBL] [Abstract][Full Text] [Related]
19. Endonuclease-resistant DNA: a novel histochemical marker for cervical intraepithelial neoplasia and cervical carcinoma.
Castellanos MR; Davidov A; Punia V; Szerszen A; Maiman M; Lazzaro B; Ahern K; Banerjee P
Int J Gynecol Pathol; 2012 Jan; 31(1):1-7. PubMed ID: 22123717
[TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical analysis of p53 oncoprotein and proliferating cell nuclear antigen (PCNA) in the cervix uteri.
Cardillo MR; Stamp GW; Pignatelli MN; Lalani EN
Eur J Gynaecol Oncol; 1993; 14(6):484-90. PubMed ID: 7910135
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
